Attached files
| file | filename |
|---|---|
| 10-K - COPYTELE, INC. 10-K - Anixa Biosciences Inc | a6160172.htm |
| EX-4.1 - EXHIBIT 4.1 - Anixa Biosciences Inc | a6160172ex4-1.htm |
| EX-4.2 - EXHIBIT 4.2 - Anixa Biosciences Inc | a6160172ex4-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Anixa Biosciences Inc | a6160172ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - Anixa Biosciences Inc | a6160172ex23-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Anixa Biosciences Inc | a6160172ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Anixa Biosciences Inc | a6160172ex32-1.htm |
| EX-32.2 - EXHIBIT 32.2 - Anixa Biosciences Inc | a6160172ex32-2.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We have issued our report dated January 14, 2009, with
respect to the consolidated financial statements and schedule included in the
Annual Report of CopyTele, Inc. and Subsidiaries on Form 10-K for the year ended
October 31, 2009. We hereby consent to the incorporation by reference
of said report in the Registration Statements of CopyTele, Inc. on Forms S-8
(Registration Nos. 33-72716, effective December 9, 1993, 33-62381, effective
September 6, 1995, 333-16933, effective November 27, 1996, 333-53416, effective
January 9, 2001, 333-69650, effective September 19, 2001, 333-99717, effective
September 18, 2002, 333-105012, effective May 5, 2003, 333-120333, effective
November 9, 2004, 333-132544, effective March 17, 2006, 333-146261, effective
September 21, 2007, and 333-156836, effective January 21, 2009).
GRANT THORNTON LLP
Melville, New York
January
29, 2010